Babu Yarlagadda S
Chief Discovery Officer at BCRX
- Sold, on record
- $2.8M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Nov 14, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BCRXBIOCRYST PHARMACEUTICALS INCChief Discovery Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BCRXPlan not statedMar 4, 2014 2014
Sold 40,642 shares at $12.57 ($511k)
Babu Yarlagadda S, Senior VP - Drug Discovery
Sold 16.3% of holdings ($3.1M position)208,195 shares leftFirst sale on recordFiling
- 2 Form 4 sale BCRXPlan not statedMar 4, 2015 +365 days
Sold 10,495 shares at $10.50 ($110k)
Babu Yarlagadda S, Senior VP - Drug Discovery
Sold 5% of holdings ($2.2M position)198,202 shares leftFiling
- 3 Form 4 sale BCRXPlan not statedMar 5, 2015 +1 day
Sold 37,400 shares at $10.59 ($396k)
Babu Yarlagadda S, Senior VP - Drug Discovery
Sold 18.9% of holdings ($2.1M position)160,802 shares leftFiling
- 4 Form 4 sale BCRXPlan not statedMar 19, 2015 +14 days
Sold 12,105 shares at $10.16 ($123k)
Babu Yarlagadda S, Senior VP - Drug Discovery
Sold 7.5% of holdings ($1.6M position)148,697 shares left0.3x usual sizeFiling
- 5 Form 4 sale BCRXPlan not statedAug 25, 2016 +525 days
Sold 30,000 shares at $4.06 ($122k)
Babu Yarlagadda S, Senior VP - Drug Discovery
Sold 21.2% of holdings ($574k position)111,428 shares left2.5x usual sizeFiling
- 6 Form 4 sale BCRXPlan not statedDec 7, 2021 +1930 days
Sold 30,100 shares at $12.20 ($367k)
Babu Yarlagadda S, Chief Discovery Officer
Sold 12.3% of holdings ($3M position)215,056 shares leftFirst sale on recordFiling
- 7 Form 4 sale BCRXPlan not statedMar 7, 2022 +90 days
Sold 20,000 shares at $17.16 ($343k)
Babu Yarlagadda S, Chief Discovery Officer
Sold 8% of holdings ($4.3M position)230,056 shares leftFiling
- 8 Form 4 sale BCRXPlan not statedNov 14, 2022 +252 days
Sold 31,515 shares at $13.88 ($437k)
Babu Yarlagadda S, Chief Discovery Officer
Sold 9.5% of holdings ($4.6M position)298,541 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | Nov 16, 2022 | BCRX | Chief Discovery Officer | Form 4 sale | 31,515 | $437k | 9.5% | Plan not stated | SEC |
| Mar 7, 2022 | Mar 9, 2022 | BCRX | Chief Discovery Officer | Form 4 sale | 20,000 | $343k | 8.0% | Plan not stated | SEC |
| Dec 7, 2021 | Dec 9, 2021 | BCRX | Chief Discovery Officer | Form 4 sale | 30,100 | $367k | 12.3% | Plan not stated | SEC |
| Aug 25, 2016 | Aug 29, 2016 | BCRX | Senior VP - Drug Discovery | Form 4 sale | 30,000 | $122k | 21.2% | Plan not stated | SEC |
| Mar 19, 2015 | Mar 20, 2015 | BCRX | Senior VP - Drug Discovery | Form 4 sale | 12,105 | $123k | 7.5% | Plan not stated | SEC |
| Mar 5, 2015 | Mar 6, 2015 | BCRX | Senior VP - Drug Discovery | Form 4 sale | 37,400 | $396k | 18.9% | Plan not stated | SEC |
| Mar 4, 2015 | Mar 5, 2015 | BCRX | Senior VP - Drug Discovery | Form 4 sale | 10,495 | $110k | 5.0% | Plan not stated | SEC |
| Mar 4, 2014 | Mar 7, 2014 | BCRX | Senior VP - Drug Discovery | Form 4 sale | 40,642 | $511k | 16.3% | Plan not stated | SEC |
| Mar 2, 2012 | Mar 5, 2012 | BCRX | VP Drug Discovery | Form 4 sale | 837 | $4k | 0.7% | Plan not stated | SEC |
| Feb 22, 2012 | Feb 23, 2012 | BCRX | VP Drug Discovery | Form 4 sale | 30,912 | $130k | 37.0% | Unusual | SEC |
| Oct 26, 2009 | Oct 28, 2009 | BCRX | VP Drug Discovery | Form 4 sale | 6,400 | $69k | 14.0% | Plan not stated | SEC |
| Oct 21, 2009 | Oct 22, 2009 | BCRX | VP Drug Discovery | Form 4 sale | 200 | $2k | 0.4% | Plan not stated | SEC |
| Oct 20, 2009 | Oct 21, 2009 | BCRX | VP Drug Discovery | Form 4 sale | 3,400 | $34k | 6.9% | Plan not stated | SEC |
| Sep 23, 2009 | Sep 24, 2009 | BCRX | VP Drug Discovery | Form 4 sale | 20,000 | $183k | 28.8% | Unusual | SEC |